chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced CHILLS (chills) and HEADACHE (headache). At the time of the report, CHILLS (chills) and HEADACHE (headache) outcome was unknown.            Concomitant medications were not reported. Treatment information in response to events was not provided.
Pt. states after the first vaccine she began to feel weak and ill approximately 1 hour after getting the vaccine.  Later in the day she developed a 102 degree fever.  Took Motrin at 8:00 pm, midnight and 4:30 am.  She had difficulty sleeping; expereinced unusual dreams.  Decided to go to the local ER for treatment; did not see the MD due to length of wait.  Returned home by 6:00 am and began feeling better by 7:00 am.  Required no additional treatment.
No symptoms were reported by the patient. No additional AE's/PQC's were noted; temperature excursion for VARlVAX/ Per caller product was administered to (1) patient.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender.  Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 21-JUN-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), dose reported as 1 (units not provided) subcutaneously (lot number: T032322 with expiration date 22-SEP-2022) for prophylaxis  (vaccination scheme frequency and anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion of 12.1 degrees Fahrenheit for 1 hour and 23 minutes, as recorded by a data logger; there was no previous temperature excursion. No symptoms were reported by the patient and there were no adverse events.
I had my first symptom of diarrhea on Tuesday Nov 9th and then Nov 10th I had congestion. On the 9th my 2 COVID tests came back negative. Friday Nov 12, I became more congested and took another test that was positive. I tried the monoclonal antibody treatment but was getting reactions to that, so I was given steroids and Benadryl on Saturday. I took another rapid test on Nov 22, and it came back negative, and symptoms have gotten better.
Parents reported 3 episodes of patient having "jerking motions" followed by a blank stare, lasted approx 30 sec, no treatment.
Extreme pain in both arms for 1-2 weeks after shots administered, lasting pain in right shoulder up to June 1, 4 months after shot.
Symptoms: Area swollen, fever, itching, pain, infection.  Treatment: Keflex (Cephalexin), Vicodin.
I was having a fever, a sore throat, and congestion. I thought I was getting the cold I usually get every year. I took a COVID-19 home test because I was having a hip surgery that Friday and it was positive. I followed up with my health care provider and they put me on Paxlovid.
TESTED COVID POSITIVE ON 06/21/2021 AFTER FULL VACCINATED
Pt was given immunizations per protocol . The next morning pt woke up with his left arm red swollen and warm to the touch.
Started out with  fever, chills,  headaches body aches and fever continued on for two days   finally on Saturday three days later the fever broke  but I still had headaches and fatigue foe two more days
left injection site arm was sore, My left arm is still occasionally sore.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (left injection site arm was sore, My left arm is still occasionally sore.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (left injection site arm was sore, My left arm is still occasionally sore.). At the time of the report, VACCINATION SITE PAIN (left injection site arm was sore, My left arm is still occasionally sore.) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-396318, MOD-2021-396324 (Patient Link).
Information has been received from a licensed practical nurse concerning an 18-week old male who on 08-AUG-2008 was vaccinated orally with the first dose of ROTATEQ vaccine live (human-bovine) (lot# not reported). No adverse effects were reported and no other information is available at this time. Patient outcome was not reported. Additional information has been requested.
I received an EKG on 14 March 2018 at 3:30PM at the Medical Clinic. I had the SHINGRIX shot at about 3:45PM. The following day I had an EKG at my cardiologists office, on 15 March 2018 at 9:15AM. The EKG showed that I had a very rapid heartbeat and I had Atrial Fibrillation. Since I had no historical record of AFib, I had a portable Zywie Heart Monitor attached to my chest for 1 week. The monitor showed that my heart had gone back to normal by 16 March 2018. Other side effects included pimples and very minor rashes. I was very tired for 3 days after the shot.
Pt cried from 11AM to 11PM; reported to MD 330PM who advised APAP, sponge bath & if fever occurs take pt to ER:
Flushing and hot flashes that have persisted 2 hours after vaccine.; Flushing and hot flashes that have persisted 2 hours after vaccine.; Notable feeling of dizziness; This is a spontaneous report from a contactable consumer (patient) and physician.  A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch # EH9899), via an unspecified route of administration on the left arm on 18Dec2020 11:15 at SINGLE DOSE for COVID-19 immunization at the hospital.  Medical history reported as none. The patient had no allergies to medications, food, or other products. There were no concomitant medications. Prior to vaccination, the patient not diagnosed with COVID-19 and the patient has not been tested for COVID-19 since the vaccination. On 18Dec2020 11:30, the patient experienced flushing and hot flashes that have persisted 2 hours after vaccine.  The patient also had notable feeling of dizziness. No treatment was received for the adverse events. Outcome of the events were not recovered.
Client vaccinated with Moderna vaccines for Covid in Feb and March 2021, boosted November 2021.  Asymptomatic.  Tested PCR + on 12/11.  History of COPD.  Social history of recently attending wedding and party, riding public transportation.  Source of illness not known.
Same day as receiving shot patient experienced hives all over trunk, open lesions around pant line, cough, discomfort. MOC is a provider and stated she had never seen anything like that as a reaction. She gave him ZYRTEC. Lesions healed by day 5.
Severe fever that lasted 18 hours, along with muscle and joint weakness that lasted for 10 days. Also lower back pain, I took ALEVE 200 mg, 2 per day until the symptoms went away.
This case was reported by a consumer (the subject's mother) and described the occurrence of stopped breathing in a 3-month-old female subject who was vaccinated with DTAP vaccine, (manufacturer unspecified).  A physician or other health care professional has not verified this report.  The subject's medical history included low birth weight and prematurity.  Previous vaccination included hepatitis B vaccine recombinant; manufacturer unspecified; unknown given on an unspecified date.  On an unspecified date in 2005 the subject received 1st dose of DTAP vaccine (details unknown).  On an unspecified date in 2005, the same year after vaccination with DTAP vaccine, the subject experienced stopped breathing and vomiting.  The consumer reported that after the DTAP vaccine, the subject stopped breathing and was revived in the hospital.  The subject then developed vomiting for several days afterwards.  The subject did not develop hives or swelling.  The subject was hospitalised.  On an unspecified date in 2005, the events were resolved.  The vaccination course with DTAP vaccine was discontinued.  The consumer reported that the subject has since been able to receive the remainder of her childhood vaccinations with the exception of the DTAP series, and none of the other vaccinations resulted in any adverse events.  Allergy testing had not revealed the cause of the reaction.  The consumer was not sure which DTAP vaccine the subject received and she refused permission to follow-up.  No further information is available.
arm pain that started after 4 days of vaccination and the pain is radiating down to their arm, going into their hand; gets achy/pain is radiating down to their arm, going into their hand; injection site is itchy; injection site got extremely swollen to about 4 inches and turned brown like a baseball; feverish; injection site got extremely swollen to about 4 inches and turned brown like a baseball; Initial information received on 18-Oct-2022 regarding an unsolicited valid  non-serious case received from a other health professional via pharmacy.  This case involves a 75 years old female patient who was feverish, injection site got extremely swollen to about 4 inches and turned brown like a baseball, arm pain that started after 4 days of vaccination, gets achy/pain is radiating down to their arm, going into their hand after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 14-Oct-2022 at 04:00 clock, the patient received a total dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE lot number not reported  at a dose of 0.7ml via unknown route in unknown administration site for immunization.  On 14-Oct-2022, the patient reported that she relates that she gets it every year and each time, she gets achy(pain) (latency: same day)and feverish (Pyrexia) (latency: same day). This time, the injection site got extremely swollen to about 4 inches and turned brown like a baseball(injection site swelling) (injection site discoloration).(latency: same day) The swelling calmed down but they still have arm pain that started after 4 days of vaccination (pain in extremity)(latency: 4 days) and the pain is radiating down to their arm, going into their hand and the injection site is itchy(injection site pruritus) (latency: same day)and wanted to know if they should be concerned regarding the side effects they are experiencing and if they can take antihistamine since they still feel uncomfortable.   Action taken :not applicable  It was not reported if the patient received a corrective treatment for the events  Outcome: recovered for injection site swelling and Recovering / Resolving for all other events
This case was reported by a other health professional via call center representative and described the occurrence of rash urticaria-like in a 3-year-old male patient who received INFANRIX (batch number 5775L, expiry date 16th October 2017. On an unknown date, the patient received INFANRIX. On an unknown date, less than a year after receiving INFANRIX, the patient experienced rash urticaria-like and skin hypopigmentation. On an unknown date, the outcome of the rash urticaria-like was not recovered/not resolved and the outcome of the skin hypopigmentation was unknown. It was unknown if the reporter considered the rash urticaria-like and skin hypopigmentation to be related to INFANRIX. Additional details were provided as follows: This case was identified as duplicated of US2016178766. Case US2016178766 was deleted and all the future correspondence will be added in the present case which stands as a case of record for this patient. The healthcare professional stated that the mother called the doctor and said that the patient developed 6-8 hive like spots on both arms following vaccination with INFANRIX. The patient also developed spots of loss of pigment on both arms. The healthcare professional while examination of the patient noticed bilateral hypo-pigmented spots on arms, and was not sure if relate to vaccination. The reporter did not know if the hive like spots turned into the hypo pigmented spots. The reporter was unsure of how long after vaccination the hives developed or resolved. The date of vaccination was not sure to be 27th October 2016 or 31st August 2016, clarification requested.
11x8cm SWELLING ON RIGHT THIGH. MOM REQUESTED TO GIVE ALL 3 VACCINES (DTAP, PREVNAR & FLU) ON THE SAME THIGH.  MEDICATION & TREATMENT STARTED ON NOV. 10, 2004.
At 15 minutes after receiving his first dose of covid vaccine, felt nauseous. Did not vomit. Became pale and diaphoretic. He sat down. Did not lose consciousness. Drank water, ate a few bites of energy bar. After ~10 minutes color returned to his skin and he was no longer diaphoretic. BP 140/100 pulse 95. Patient has several other similar episodes after donating blood.
felt sicker with the Vaccine than with the Covid; felt nausea; vomiting; chills; headaches; back ache; was debilitating; This spontaneous case was reported by a nurse and describes the occurrence of BACK PAIN (back ache), ASTHENIA (was debilitating), MALAISE (felt sicker with the Vaccine than with the Covid), CHILLS (chills) and HEADACHE (headaches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L210A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (she was  tested positive for Covid on 27Apr2020) on 27-Apr-2020, Hysterectomy and Surgery (lap band surgery, carpal tunnel surgery, and left shoulder surgery 2 times.). Concurrent medical conditions included Drug allergy (Allergies to Sulfas). Concomitant products included LEVOTHYROXINE, LOSARTAN POTASSIUM (LOSARTIN) and DICLOFENAC for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced BACK PAIN (back ache), ASTHENIA (was debilitating), CHILLS (chills) and HEADACHE (headaches). On 06-Jan-2021, the patient experienced MALAISE (felt sicker with the Vaccine than with the Covid), NAUSEA (felt nausea) and VOMITING (vomiting). At the time of the report, BACK PAIN (back ache), ASTHENIA (was debilitating), MALAISE (felt sicker with the Vaccine than with the Covid), CHILLS (chills), HEADACHE (headaches), NAUSEA (felt nausea) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2020, SARS-CoV-2 antibody test positive: positive (Positive) she was  tested positive for Covid on 27Apr2020.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment of the events was reported as none.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
The vial was opened on 10Aug2022, but a dose of that was administered 09Sep2022; No Adverse event; Dose given from a vial punctured more than 12 hours ago; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose given from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (The vial was opened on 10Aug2022, but a dose of that was administered 09Sep2022) and NO ADVERSE EVENT (No Adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 09-Sep-2022 at 10:00 AM, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Sep-2022 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose given from a vial punctured more than 12 hours ago). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was opened on 10Aug2022, but a dose of that was administered 09Sep2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose given from a vial punctured more than 12 hours ago), PRODUCT STORAGE ERROR (The vial was opened on 10Aug2022, but a dose of that was administered 09Sep2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose given from a vial punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (The vial was opened on 10Aug2022, but a dose of that was administered 09Sep2022).    Concomitant product use was not provided by the reporter.  The vial was opened on 10-Aug-2022 and was first punctured at 09 AM and administered dose on 09-Sep-2022 at 10 AM. The vial was stored in fridge post puncture. The vial did not undergo any temperature excursions. The vial was exposed to room temperature range (8° to 25°C - 46° to 77°F) for 30 minutes.  Pharmacist does know that more than 12 hours elapsed and after that time at least one patient received the Moderna Monovalent Covid-19 vaccine more than 12 hours post puncture.  The patient received the dose from a vial punctured more than 12 hours ago.  Treatment information was not provided.
8 Days after the shot, acquired a red, round, itchy rash patch on same arm, near shot site. Treating with Benadryl cream on the site, will add a Benadryl pill if needed.
pt felt dizzy and like she was thirsty about 8 minutes after the vaccine. I took her bp and it was elevated and I gave her a cool cloth for her neck. we talked about vasovagal reactions. she then stated that her throat was itchy and felt like it was closing up. we called 911 and I administered her first Epinephrine 0.3mg dose at 5:11, she felt better, bp still elevated. her throat got itchy and felt like it was closing again so I gave her another dose at 5:17. the paramedics arrived at 5:19 and took the patient to the hospital across the street.
Her arm is very painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm is very painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm is very painful). At the time of the report, PAIN IN EXTREMITY (Her arm is very painful) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.
8 DAYS AFTER ANTHRAX SHOT (#3), PRESENTED ABDOMINAL PAIN, NAUSEA, LOOSE STOOLS.
A1C jumped in 3-4 months from 6.8 (08/03/2022) to 11 (01/05/2022) since after my last COVID-19 Moderna Bivalent booster (09/29/2022).
pt rcvd vax; pt exp'd pain in right quadrant near the liver intermittently during dy up to 4 wks; w/ 3rd dose symptoms returned but less severe & exp inc in intestinal gas;
Alternating extreme fussiness with sleepiness. Legs with patchy red and blue areas 7 x 9 cm very tender induration (L) upper lateral thigh. (+) scattered petechiae on legs. Rest of skin & exam nl.
17 May 2010-12 ds post SPV....Brought to hospital by ambulance at approx 0345 reporting onset of mid retrosternal chest pain, SOB and lightheadedness about one hour prior. Described pain as 9/10. Described difficulty getting a deep breath. Vitals on scene were pulse in 80's, BP 142/p, SaO2 98% on RA. O2 at 2LNC was applied on scene. Pt arrived in hospital stating pain still 9/10. No nausea or diaphoresis but sl lightheaded and SOB. No palpitations. Denies any episodes of similar sx. Pt arrived at location 3 days ago. Had received his smallpox vaccine on 5 May. No h/o of URI or other viral illness in the last several months. Denied any OTC or prescribed meds and denied any supplement use. States he had been hydrating well but felt overheated two days prior after doing hand to hand combat training". Post vaccinia myocarditis.
Redness from site injection in upper left arm down to below elbow. Slight swelling and stiffness. Patient came to pharmacy on 9/29/17 at 1:30pm to show arm which was red. Patient advised to take BENADRYL and to ice area. He confirmed that swelling, redness and stiffness was decreasing.
Facial numbness, chills, headache, restless legs, neck pain, ear fullness, severe vertigo
This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 prophylaxis. The patient's past medical history included Artery dissection. Concurrent medical conditions included Fibromuscular dysplasia since January 2013 and Migraine (Visits neurologist about once a year of migraines). Concomitant products included WARFARIN for Fibromuscular dysplasia, UBROGEPANT (UBRELVY) for Migraine. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). In March 2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. It was reported that patient had recovered after a day and so and proceeded with living life with no after effects of the vaccine. No treatment medication were reported. This case was linked to MOD-2022-639577 (Patient Link).
PATIENT DEVELOPED PROGRESSIVE NEW DYSPNEA, DIFFERENT FROM HER BASELINE. SHE HAS BEEN HOSPITALIZED TWICE FOR PERSISTENT DYSPNEA AND CENTRALIZED CHEST PAIN, WHICH HAS OTHERWISE HAD NEGATIVE WORK UP.
This spontaneous report was received from   a healthcare worker refers to a female patient of unknown age with no pertinent medical history and no drug reactions/allergies. The patient was vaccinated with the first dose of hepatitis B vaccine (recombinant)(manufacturer unknown) on 29-NOV-1995, the second dose on 03-JAN-1996 and the third dose on 21-AUG-1996. The patient was also vaccinated with RECOMBIVAX HB (lot # reported as J0007222, expiration: 17-SEP-2015), 0.5 ml intramuscularly on 03-AUG-2013. There was no concomitant medication. The healthcare worker reported that the patient received an unspecified hepatitis B vaccination when she was "younger" (see above dates, and on approximately 23-JUL-2013 ("about two weeks" ago) titers were drawn on the patient and the results showed that the patient was not immune. The healthcare worker reported that the patient had titers drawn because it was required for her college. The healthcare worker reported that the patient was administered RECOMBIVAX HB on 03-AUG-2013 due to her titers showing no immunity and required for college. The outcome of titer showing no immunity was unknown. Additional information has been requested.
Severe chills and shaking, fever up to 101.8. Started at 1130pm took ibuprofen at 0230am and rotated tylenol and ibuprofen every 4 hours no other issues
Severe Angina ( as if heart was jumping out chest) Weakness (could barely walk feeling of passing out  Disorentated incapacitated  Swollen lymph nodes resulting in biopsy surgery